Macular Chats

Clinical trials are essential to advancing care for age‑related macular degeneration (AMD) and geographic atrophy (GA). In this episode, Mathew MacCumber, MD, PhD, explains how clinical trials work, the potential benefits and challenges of participation, and key factors to consider when deciding whether a trial may be right for you. The discussion will also include a high-level overview of the GAL...

Researchers are exploring whether cell therapy—including stem cells and stem cell–derived treatments—could help repair or replace damaged retinal cells in macular degeneration and geographic atrophy. In this episode, we explain how these therapies are intended to work, how the cells may be delivered to the eye, and the potential risks.

In this interactive episode, Dr. Joshua Dunaief answers listener questions about macular degeneration. From understanding the different types of AMD to the role of supplements and nutrition, tips for daily living, and treatment options, this conversation is designed to address the topics that matter most to you. Join us to hear practical insights from a leading expert.

Staying on schedule with wet age-related macular degeneration (AMD) treatment is one of the most important ways to protect your vision. In this episode, Manuel Amador, MD, explains today’s wet AMD treatments and why consistency matters. He will also share practical tips on early detection, risk factors, and taking an active role in your eye health.

What if an artificial retina or another type of electronic implant could restore vision? Unlike current therapies that only slow the progression of the disease, retinal prostheses are designed to actually restore vision for people with retinal degeneration. In this Macular Chats episode, we explore this emerging field and break down the different types of implants in development, including the PRI...